AMPA antagonists (Knoll/BASF)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAMPA antagonists (Knoll/BASF)
Drug Alias Namepyrrolylquinoxaline-2,3-diones
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsNerve DegenerationEpilepsyStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKnoll Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKnoll Gmbh
Active IndicationsN/A
Inactive IndicationsNerve DegenerationEpilepsyStroke

Other Information

ATC CodeN/A
Related LinksN/A